![](/img/cover-not-exists.png)
Changes in the concentration of EGFR-mutated (EGFR-M+) plasma DNA in the first hours of TKI therapy allow the prediction of tumour response in patients with EGFR-M+ NSCLC
Kuligina, E.S., Moiseenko, F.V., Belukhin, S.A., Laidus, T.A., Martianov, A.S., Gabina, A.S., Myslik, A.V., Volkov, N.M., Zagorodnev, K.A., Kholmatov, M.M., Sokolova, T.N., Stepanova, M.L., Shuginova,Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.091
Date:
September, 2020
File:
PDF, 75 KB
2020